VC Deals Analysis: How Four Bad Months Can Spoil The Barrel
Executive Summary
Another slow month for VC financing deals means total deal value for 2016 to date is now lagging behind that for the same period last year.
You may also be interested in...
VC Deals Analysis: One Big Beat After Long Lull
After a slow summer, September delivered a much welcomed boost to venture funding levels with the first nine-figure deal in four months.
VC DEAL ANALYSIS: Does Trend-Bucking August Signal Boom Year For Venture Financing?
August may be called the silly season for the news industry but for the medtech sector, last month saw serious money being raised privately by start-ups and growing SMEs.
Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.